The Shape of Things to Come

Networks explain the Multiverse of Data

Stephan Reichl (AT)

| | |

Cancer therapies and their success depend on various factors. The approach towards immune checkpoint inhibitors provided novel therapeutic options for patients. However, developing resistance remains a challenge. Observing this resistance to treatment and therapy through analysis such as CRISPR screening approaches can help understand the role of immune checkpoint inhibitors, enhancing possibilities in the future for more advanced cancer therapy methods.